Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Scott Feldman, M.D.

Co-Author

This page shows the publications co-authored by Adam Feldman and Mark Preston.
Connection Strength

1.153
  1. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. J Urol. 2019 04; 201(4):721-727.
    View in: PubMed
    Score: 0.208
  2. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 08 10; 34(23):2705-11.
    View in: PubMed
    Score: 0.171
  3. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-14.
    View in: PubMed
    Score: 0.166
  4. Role of imaging in testicular cancer: current and future practice. Future Oncol. 2015 Sep; 11(18):2575-86.
    View in: PubMed
    Score: 0.162
  5. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
    View in: PubMed
    Score: 0.159
  6. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases. Urol Oncol. 2014 Oct; 32(7):958-65.
    View in: PubMed
    Score: 0.150
  7. Testicular cancer: what the radiologist needs to know. AJR Am J Roentgenol. 2013 Jun; 200(6):1215-25.
    View in: PubMed
    Score: 0.139
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.